Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

Perou CM(2000)Molecular portraits of human breast tumours Nature. 406 747-752

Sørlie T(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-10874

Eisen MB(2006)The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96-1167

van de Rijn M(2009)Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 1160-345

Jeffrey SS(2014)Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 risk of recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone Ann Oncol 25 339-2790

Rees CA(2013)Comparison of PAM50 risk of recurrence score with Oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy J Clin Oncol 31 2783-325

Sørlie T(2008)Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 317-5232

Perou CM(2011)mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol 11 46-482

Tibshirani R(2014)Comparison of RNA-Seq by poly (a) capture, ribosomal RNA depletion, and DNA microarray for expression profiling BMC Genomics 15 1-57

Aas T(2010)A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast Cancer Clin Cancer Res 16 5222-2378

Perou CM(2000)Molecular portraits of human breast tumours Nature. 406 747-752

Sørlie T(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-10874

Eisen MB(2006)The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96-1167

van de Rijn M(2009)Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 1160-345

Jeffrey SS(2014)Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 risk of recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone Ann Oncol 25 339-2790

Rees CA(2013)Comparison of PAM50 risk of recurrence score with Oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy J Clin Oncol 31 2783-325

Sørlie T(2008)Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 317-5232

Perou CM(2011)mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol 11 46-482

Tibshirani R(2014)Comparison of RNA-Seq by poly (a) capture, ribosomal RNA depletion, and DNA microarray for expression profiling BMC Genomics 15 1-57

Aas T(2010)A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast Cancer Clin Cancer Res 16 5222-2378